Skip to main navigation
Skip to search
Skip to main content
Universidad de los Andes Home
English
Español
Home
Profiles
Research units
Research output
Projects
Press/Media
Activities
Equipment
Student theses
Prizes
Courses
Impacts
Search by expertise, name or affiliation
PPARγ in head and neck cancer prevention
Mauricio Burotto, Eva Szabo
*
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
23
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'PPARγ in head and neck cancer prevention'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Head Cancer Prevention
100%
Head and Neck Cancer
100%
Neck Cancer Prevention
100%
Peroxisome Proliferator Activated Receptor Gamma
100%
Carcinogenesis
66%
Disease
33%
In Vitro
33%
Cancer Growth
33%
Diabetes
33%
High-Risk Population
33%
Chemoprophylaxis
33%
Oral Cancer
33%
Thiazolidinedione
33%
Chemotherapy
33%
Keyphrases
Peroxisome Proliferator-activated Receptor
100%
Cancer Prevention
100%
Head-and-neck Cancer
100%
Curb
33%
Growth in Vitro
33%
Concomitant Chemotherapy
33%
Oncogenesis
33%
Thiazolidinediones
33%
Carcinogenesis Models
33%
Diabetes Management
33%
Chemoprevention
33%
Treatment Modalities
33%
Population at Risk
33%
Oral Cancer
33%
Cancer Cell Growth
33%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor Gamma
100%
Head and Neck Cancer
100%
Carcinogenesis
66%
Disease
33%
Chemotherapy
33%
Thiazolidinedione
33%
Mouth Cancer
33%
Cancer Growth
33%